Latest news
Cardiovascular Risk Management in T2D with established ASCVD: Current Evidence for Dapagliflozin and... - Medical DialoguesMedical Dialogues · Wed, 05 Aug 2026 05:13:30 GMTExperts Discuss Assessing Cardiovascular Risk Before Noncardiac Surgery in a Patient with Complex Medical Conditions | Newswise - NewswiseNewswise · Tue, 04 Aug 2026 23:00:00 GMT